This is because the variation and extended haplotype structure of LDLR in different ethnic groups remains largely unknown, for example, in patients with altered lipid metabolism, Mendelian FH, and common diseases (CAD and Alzheimer’s disease). This evidence concerns the gene LDLR and familial hyperaldosteronism.